Advanced
  Home Compare Reports

Comparison with Similar Reports

Minimally Invasive Surgical Instruments Market by Product (Handheld Instruments, Inflation Devices, Surgical Scopes), Type of Surgery (Cardiothoracic,...

Publisher:        MarketsandMarkets

# of Pages:        276

Rating: 

1 User License $4,950

Publication Date:  September, 2021

Price:       $4,950 / User License




1 INTRODUCTION 23
1.1 OBJECTIVES OF THE STUDY 23
1.2 MARKET DEFINITION 23
1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY 24
1.2.2 MARKETS COVERED 25
FIGURE 1 MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SEGMENTATION 25
1.2.3 YEARS CONSIDERED FOR THE STUDY 26
1.3 CURRENCY 26
1.4 LIMITATIONS 26
1.5 STAKEHOLDERS 27
1.6 SUMMARY OF CHANGES 27
2 RESEARCH METHODOLOGY 29
2.1 RESEARCH DATA 29
2.2 RESEARCH APPROACH 29
FIGURE 2 MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET: RESEARCH DESIGN 29
2.2.1 SECONDARY DATA 30
2.2.1.1 Key data from secondary sources 30
2.2.2 PRIMARY DATA 31
2.2.2.1 Primary sources 32
2.2.2.2 Key data from primary sources 33
2.2.2.3 Key industry insights 34
2.2.2.4 Breakdown of primary interviews 34
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS (MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET) 34
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 35
2.3 MARKET SIZE ESTIMATION 35
2.3.1 BOTTOM-UP APPROACH 36
2.3.1.1 Approach 1: Company revenue estimation approach 36
FIGURE 5 BOTTOM-UP APPROACH: COMPANY REVENUE ESTIMATION APPROACH 36
2.3.1.2 Approach 2: Presentations of companies and primary interviews 36
2.3.1.3 Growth forecast 37
2.3.1.4 CAGR projections 37
FIGURE 6 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 37
2.3.2 TOP-DOWN APPROACH 37
FIGURE 7 MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET: TOP-DOWN APPROACH 38
2.4 MARKET BREAKDOWN & DATA TRIANGULATION 39
FIGURE 8 DATA TRIANGULATION METHODOLOGY 39
2.5 MARKET SHARE 40
2.6 ASSUMPTIONS FOR THE STUDY 40
2.7 LIMITATIONS 41
2.8 RISK ASSESSMENT 41
2.8.1 RISK ASSESSMENT: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET 41
2.9 GROWTH RATE ASSUMPTIONS 42
2.10 COVID-19 HEALTH ASSESSMENT 42
2.11 COVID-19 ECONOMIC ASSESSMENT 42
2.12 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO 42
FIGURE 9 CRITERIA IMPACTING THE GLOBAL ECONOMY 43
FIGURE 10 RECOVERY SCENARIO OF THE GLOBAL ECONOMY 44
2.13 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET 45
3 EXECUTIVE SUMMARY 46
FIGURE 11 MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY PRODUCT, 2021 VS. 2026 (USD MILLION) 46
FIGURE 12 MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY TYPE OF SURGERY, 2021 VS. 2026 (USD MILLION) 47
FIGURE 13 MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY END USER, 2021 VS. 2026 (USD MILLION) 48
FIGURE 14 MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY REGION,
2021 VS. 2026 (USD MILLION) 49
4 PREMIUM INSIGHTS 50
4.1 MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET OVERVIEW 50
FIGURE 15 THE GROWING PREVALENCE OF TARGET DISEASES AND THE INCREASING NUMBER OF SURGERIES WORLDWIDE DRIVE THE MARKET GROWTH 50
4.2 MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SHARE, BY PRODUCT,
2021 VS. 2026 51
FIGURE 16 THE HANDHELD INSTRUMENTS SEGMENT WILL CONTINUE TO DOMINATE THE MARKET IN 2026 51
4.3 MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SHARE, BY TYPE OF SURGERY, 2021 VS. 2026 51
FIGURE 17 CARDIOTHORACIC SURGERY SEGMENT TO DOMINATE THE MARKET DURING THE FORECAST PERIOD 51
4.4 MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SHARE, BY END USER,
2021 VS. 2026 52
FIGURE 18 HOSPITALS AND SPECIALTY CLINICS SEGMENT TO CONTINUE TO DOMINATE THE MARKET IN 2026 52
4.5 MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 52
FIGURE 19 ASIA PACIFIC TO REGISTER THE HIGHEST GROWTH RATE IN THE MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET DURING THE FORECAST PERIOD 52
 
5 MARKET OVERVIEW 53
5.1 INTRODUCTION 53
5.2 MARKET DYNAMICS 53
FIGURE 20 MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 53
5.2.1 DRIVERS 53
5.2.1.1 Increasing number of surgical procedures worldwide 53
TABLE 1 PERCENTAGE INCREASE IN NUMBER OF SURGERIES PERFORMED IN THE US 55
TABLE 2 NUMBER OF MINIMALLY INVASIVE LAPAROSCOPIC COLECTOMY PROCEDURES, BY COUNTRY/REGION (2014-2018) 55
TABLE 3 NUMBER OF MINIMALLY INVASIVE LAPAROSCOPIC APPENDECTOMY PROCEDURES, BY COUNTRY/REGION (2014-2018) 56
TABLE 4 NUMBER OF MINIMALLY INVASIVE LAPAROSCOPIC CHOLECYSTECTOMY PROCEDURES, BY COUNTRY/REGION (2014-2018) 56
TABLE 5 NUMBER OF MINIMALLY INVASIVE LAPAROSCOPIC INGUINAL HERNIA REPAIR PROCEDURES, BY COUNTRY/REGION (2014-2018) 57
TABLE 6 NUMBER OF MINIMALLY INVASIVE LAPAROSCOPIC HYSTERECTOMY PROCEDURES, BY COUNTRY/REGION, 2014-2018 57
5.2.1.2 Advantages of MIS over open surgical techniques 58
5.2.2 RESTRAINTS 58
5.2.2.1 Changing regulatory landscape in the medical device industry 58
5.2.3 OPPORTUNITIES 59
5.2.3.1 Emerging markets 59
5.2.3.2 Increasing adoption of advanced robotics in ASCs 59
5.2.4 CHALLENGES 60
5.2.4.1 High degree of market consolidation 60
5.3 IMPACT OF COVID-19 ON THE MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET 60
5.4 PESSIMISTIC, OPTIMISTIC, AND REALISTIC SCENARIOS 62
5.4.1 MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET 62
FIGURE 21 PESSIMISTIC SCENARIO 62
FIGURE 22 OPTIMISTIC SCENARIO 62
FIGURE 23 REALISTIC SCENARIO 63
5.5 PRICING ANALYSIS 63
TABLE 7 PRICE OF MINIMALLY INVASIVE SURGICAL INSTRUMENTS (2021) 63
5.6 PATENT ANALYSIS 64
5.6.1 PATENT ANALYSIS OF SUTURING INSTRUMENTS 64
5.6.2 PATENT ANALYSIS OF ELECTROSURGICAL INSTRUMENTS 65
5.7 TRADE ANALYSIS 66
5.7.1 TRADE ANALYSIS FOR NEEDLES, CATHETERS, AND CANNULAS 66
TABLE 8 IMPORT DATA FOR NEEDLES, CATHETERS, AND CANNULAS, BY COUNTRY, 2016–2020 (USD MILLION) 66
TABLE 9 EXPORT DATA FOR NEEDLES, CATHETERS, AND CANNULAS, BY COUNTRY, 2016–2020 (USD MILLION) 66
 
5.8 VALUE CHAIN ANALYSIS 67
FIGURE 24 MAJOR VALUE IS ADDED DURING THE MANUFACTURING & ASSEMBLY PHASE 67
5.9 SUPPLY CHAIN ANALYSIS 68
FIGURE 25 MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET: SUPPLY CHAIN ANALYSIS 69
5.10 ECOSYSTEM ANALYSIS OF THE MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET 69
FIGURE 26 MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET: ECOSYSTEM ANALYSIS 69
5.10.1 ROLE IN ECOSYSTEM 70
5.11 PORTER’S FIVE FORCES ANALYSIS 70
TABLE 10 MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET: PORTER’S FIVE FORCES ANALYSIS 70
5.11.1 THREAT OF NEW ENTRANTS 71
5.11.2 THREAT OF SUBSTITUTES 71
5.11.3 BARGAINING POWER OF BUYERS 71
5.11.4 BARGAINING POWER OF SUPPLIERS 71
5.11.5 DEGREE OF COMPETITION 71
5.12 REGULATORY LANDSCAPE 71
5.12.1 NORTH AMERICA 72
5.12.1.1 US 72
5.12.1.2 Canada 72
5.12.2 EUROPE 72
5.12.3 ASIA PACIFIC 72
5.12.3.1 Japan 72
5.12.3.2 India 72
5.12.4 LATIN AMERICA 73
5.12.4.1 Brazil 73
5.12.4.2 Mexico 73
5.12.5 MIDDLE EAST 73
5.13 CASE STUDY ANALYSIS 74
5.13.1 CASE STUDY 1 74
5.13.2 CASE STUDY 2 74
5.14 TECHNOLOGY ANALYSIS 75
5.15 TRENDS/DISRUPTIONS IMPACTING THE BUSINESS OF CUSTOMERS 76
5.15.1 REVENUE SOURCES ARE SHIFTING TOWARDS TECHNOLOGY-BASED SOLUTIONS DUE TO THE COVID-19 PANDEMIC 76
5.15.2 REVENUE SHIFT FOR THE MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET 76
6 MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY PRODUCT 77
6.1 INTRODUCTION 78
TABLE 11 MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 78
TABLE 12 MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY TYPE,
2019–2026 (MILLION UNITS) 79
6.2 HANDHELD INSTRUMENTS 79
6.2.1 PRIMARY NOTES 80
6.2.1.1 Key industry insights 80
TABLE 13 KEY PRODUCTS IN THE HANDHELD INSTRUMENTS MARKET 80
TABLE 14 HANDHELD INSTRUMENTS MARKET, BY REGION, 2019–2026 (USD MILLION) 80
TABLE 15 HANDHELD INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION) 81
6.2.2 GRASPERS 81
6.2.2.1 Increasing focus on patient safety to drive the market growth 81
TABLE 16 KEY PRODUCTS IN THE GRASPERS MARKET 81
TABLE 17 GRASPERS MARKET, BY REGION, 2019–2026 (USD MILLION) 82
6.2.3 RETRACTORS/ELEVATORS 82
6.2.3.1 The growing number of spinal, orthopedic, and endoscopic surgical procedures to support the adoption of retractors/elevators 82
TABLE 18 KEY PRODUCTS IN THE RETRACTORS/ELEVATORS MARKET 83
TABLE 19 RETRACTORS/ELEVATORS MARKET, BY REGION, 2019–2026 (USD MILLION) 83
6.2.4 SUTURING INSTRUMENTS 84
6.2.4.1 The shortage of skilled professionals for the handling of sutures is a key factor restraining the market growth of this segment 84
TABLE 20 KEY PRODUCTS IN THE SUTURING INSTRUMENTS MARKET 84
TABLE 21 SUTURING INSTRUMENTS MARKET, BY REGION, 2019–2026 (USD MILLION) 85
6.2.5 DILATORS 85
6.2.5.1 Dilators assist in making a tunnel through an incision, thus providing clear images of internal organs 85
TABLE 22 DILATORS MARKET, BY REGION, 2019–2026 (USD MILLION) 86
6.2.6 OTHER HANDHELD INSTRUMENTS 86
TABLE 23 KEY PRODUCTS IN THE OTHER HANDHELD INSTRUMENTS MARKET 87
TABLE 24 OTHER HANDHELD INSTRUMENTS MARKET, BY REGION,
2019–2026 (USD MILLION) 87
6.3 INFLATION DEVICES 88
TABLE 25 INFLATION DEVICES MARKET, BY REGION, 2019–2026 (USD MILLION) 88
TABLE 26 INFLATION DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 89
6.3.1 BALLOONS 89
6.3.1.1 The growing number of angioplasty procedures to drive the growth of this market segment 89
TABLE 27 BALLOONS MARKET, BY REGION, 2019–2026 (USD MILLION) 90
6.3.2 BALLOON INFLATION DEVICES 90
6.3.2.1 Balloon inflation devices provide safe dilation with minimum mucosal strain 90
TABLE 28 BALLOON INFLATION DEVICES MARKET, BY REGION,
2019–2026 (USD MILLION) 91
6.4 SURGICAL SCOPES 91
TABLE 29 KEY PRODUCTS IN THE SURGICAL SCOPES MARKET 91
TABLE 30 SURGICAL SCOPES MARKET, BY REGION, 2019–2026 (USD MILLION) 92
TABLE 31 SURGICAL SCOPES MARKET, BY TYPE, 2019–2026 (USD MILLION) 92
TABLE 32 SURGICAL SCOPES MARKET, BY TYPE, 2019–2026 (MILLION UNITS) 93
6.4.1 LAPAROSCOPES 93
6.4.1.1 The increasing number of laparoscopic surgeries and reduction in the overall surgery cost drive the growth of the market 93
TABLE 33 KEY PRODUCTS IN THE LAPAROSCOPES MARKET 94
6.4.2 UROLOGY ENDOSCOPES 94
6.4.2.1 The growing prevalence of urinary tract infections is expected to increase the number of urology endoscopic procedures 94
6.4.3 ARTHROSCOPES 95
6.4.3.1 Increasing prevalence of rheumatoid arthritis and hip & knee arthroscopy to drive the growth of this segment 95
TABLE 34 KEY PRODUCTS IN THE ARTHROSCOPES MARKET 95
6.4.4 NEUROENDSCOPES 96
6.4.4.1 The increasing prevalence of brain cancer drives the demand for neuroendoscopy procedures 96
6.4.5 OTHER SURGICAL SCOPES 97
6.5 CUTTING INSTRUMENTS 97
TABLE 35 KEY PRODUCTS IN THE CUTTING INSTRUMENTS MARKET 97
TABLE 36 CUTTING INSTRUMENTS MARKET, BY REGION, 2019–2026 (USD MILLION) 98
TABLE 37 CUTTING INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION) 98
6.5.1 TROCARS 98
6.5.1.1 Improved trocar designs result in reduced complication- a key factor driving the market growth of this segment 98
TABLE 38 KEY PRODUCTS IN THE TROCARS MARKET 99
TABLE 39 TROCARS MARKET, BY REGION, 2019–2026 (USD MILLION) 99
6.5.2 OTHER CUTTING INSTRUMENTS 100
TABLE 40 KEY PRODUCTS IN THE OTHER CUTTING INSTRUMENTS MARKET 100
TABLE 41 OTHER CUTTING INSTRUMENTS MARKET, BY REGION,
2019–2026 (USD MILLION) 101
6.6 GUIDING DEVICES 101
TABLE 42 GUIDING DEVICES MARKET, BY REGION, 2019–2026 (USD MILLION) 102
TABLE 43 GUIDING DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 102
6.6.1 GUIDING CATHETERS 102
6.6.1.1 The availability of customized catheters for specific inventions is driving the growth of this segment 102
TABLE 44 KEY PRODUCTS IN THE GUIDING CATHETERS MARKET 103
TABLE 45 GUIDING CATHETERS MARKET, BY REGION, 2019–2026 (USD MILLION) 103
6.6.2 GUIDEWIRES 103
6.6.2.1 Efficient guiding and tracking capabilities of guidewires drives its adoption for complex surgeries 103
TABLE 46 KEY PRODUCTS IN THE GUIDEWIRES MARKET 104
TABLE 47 GUIDEWIRES MARKET, BY REGION, 2019–2026 (USD MILLION) 104
6.7 ELECTROSURGICAL & ELECTROCAUTERY INSTRUMENTS 105
TABLE 48 KEY PRODUCTS IN THE ELECTROSURGICAL & ELECTROCAUTERY INSTRUMENTS MARKET 105
TABLE 49 ELECTROSURGICAL & ELECTROCAUTERY INSTRUMENTS MARKET,
BY REGION, 2019–2026 (USD MILLION) 106
TABLE 50 ELECTROSURGICAL & ELECTROCAUTERY INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION) 106
6.7.1 ELECTROSURGICAL INSTRUMENTS 106
6.7.1.1 Electrosurgical instruments are expected to grow at the highest CAGR during the forecast period 106
TABLE 51 KEY PRODUCTS IN THE ELECTROSURGICAL INSTRUMENTS MARKET 107
TABLE 52 ELECTROSURGICAL INSTRUMENTS MARKET, BY REGION,
2019–2026 (USD MILLION) 108
6.7.2 ELECTROCAUTERY DEVICES 109
6.7.2.1 Increasing number of plastic surgeries to drive the market growth for electrocautery devices 109
TABLE 53 ELECTROCAUTERY DEVICES MARKET, BY REGION,
2019–2026 (USD MILLION) 109
6.8 OTHER INSTRUMENTS 109
TABLE 54 KEY PRODUCTS IN THE OTHER INSTRUMENTS MARKET 110
TABLE 55 OTHER INSTRUMENTS MARKET, BY REGION, 2019–2026 (USD MILLION) 111
7 MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET,
BY TYPE OF SURGERY 112
7.1 INTRODUCTION 113
TABLE 56 MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY TYPE OF SURGERY, 2019–2026 (USD MILLION) 113
7.2 CARDIOTHORACIC SURGERY 113
7.2.1 THE GROWING BURDEN OF CVD IS A KEY FACTOR DRIVING THE MARKET GROWTH 113
TABLE 57 MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET FOR CARDIOTHORACIC SURGERY, BY REGION, 2019–2026 (USD MILLION) 115
7.3 GASTROINTESTINAL SURGERY 115
7.3.1 THE INCREASING PREVALENCE OF COLORECTAL CANCER IS EXPECTED TO DRIVE THE GROWTH OF THIS SEGMENT 115
TABLE 58 MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET FOR GASTROINTESTINAL SURGERY, BY REGION, 2019–2026 (USD MILLION) 116
7.4 ORTHOPEDIC SURGERY 116
7.4.1 THE INCREASING GERIATRIC POPULATION AND THE SUBSEQUENT INCREASE IN ORTHOPEDIC AILMENTS IS EXPECTED TO DRIVE THE GROWTH OF THIS SEGMENT 116
TABLE 59 MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET FOR ORTHOPEDIC SURGERY, BY REGION, 2019–2026 (USD MILLION) 118
7.5 GYNECOLOGICAL SURGERY 118
7.5.1 THE GROWING NUMBER OF LAPAROSCOPIC HYSTERECTOMIES PERFORMED IS EXPECTED TO SUPPORT THE MARKET GROWTH 118
TABLE 60 LAPAROSCOPIC HYSTERECTOMY PROCEDURES PERFORMED IN HOSPITALS (PER 100,000 INHABITANTS), BY COUNTRY, 2013 VS. 2018 119
TABLE 61 MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET FOR GYNECOLOGICAL SURGERY, BY REGION, 2019–2026 (USD MILLION) 119
7.6 COSMETIC & BARIATRIC SURGERY 120
7.6.1 INCREASING PREVALENCE OF OBESITY AND GROWING PREFERENCE FOR COSMETIC PROCEDURES TO DRIVE THE MARKET GROWTH 120
TABLE 62 MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET FOR COSMETIC & BARIATRIC SURGERY, BY REGION, 2019–2026 (USD MILLION) 121
7.7 UROLOGICAL SURGERY 121
7.7.1 INCREASING PREVALENCE OF UROLOGIC CANCERS TO DRIVE THE ADOPTION OF MIS FOR THIS SEGMENT 121
TABLE 63 MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET FOR UROLOGICAL SURGERY, BY REGION, 2019–2026 (USD MILLION) 122
7.8 OTHER SURGERIES 122
TABLE 64 MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET FOR OTHER SURGERIES, BY REGION, 2019–2026 (USD MILLION) 123
8 MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY END USER 124
8.1 INTRODUCTION 125
TABLE 65 MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY END USER, 2019–2026 (USD MILLION) 125
8.2 HOSPITALS AND SPECIALTY CLINICS 125
8.2.1 THE INCREASING NUMBER OF HOSPITALS AND GOVERNMENT INVESTMENTS TO DRIVE THE GROWTH OF THIS SEGMENT 125
TABLE 66 MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET FOR HOSPITALS AND SPECIALTY CLINICS, BY REGION, 2019–2026 (USD MILLION) 126
8.3 AMBULATORY SURGERY CENTERS (ASCS) 127
8.3.1 LOWER COSTS AND SHORTER PATIENT STAYS TO PROPEL THE GROWTH OF THIS END-USER SEGMENT 127
8.3.2 PRIMARY NOTES 128
8.3.2.1 Key industry insights 128
TABLE 67 MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET FOR ASCS,
BY REGION, 2019–2026 (USD MILLION) 128
9 MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY REGION 129
9.1 INTRODUCTION 130
TABLE 68 MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY REGION,
2019–2026 (USD MILLION) 130
9.2 NORTH AMERICA 130
FIGURE 27 NORTH AMERICA: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SNAPSHOT 131
TABLE 69 NORTH AMERICA: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 132
TABLE 70 NORTH AMERICA: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 132
TABLE 71 NORTH AMERICA: HANDHELD INSTRUMENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 133
TABLE 72 NORTH AMERICA: INFLATION DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 133
TABLE 73 NORTH AMERICA: CUTTING INSTRUMENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 133
TABLE 74 NORTH AMERICA: GUIDING DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 134
TABLE 75 NORTH AMERICA: ELECTROSURGICAL & ELECTROCAUTERY INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION) 134
TABLE 76 NORTH AMERICA: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY TYPE OF SURGERY, 2019–2026 (USD MILLION) 134
TABLE 77 NORTH AMERICA: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY END USER, 2019–2026 (USD MILLION) 135
TABLE 78 NORTH AMERICA: ENDOSCOPIC GASTROINTESTINAL SURGERY MARKET FOR ESOPHAGEAL STRICTURES, BY PRODUCT, 2018–2025 (USD MILLION) 135
TABLE 79 NORTH AMERICA: ENDOSCOPIC GASTROINTESTINAL SURGERY MARKET FOR ENDOSCOPIC STRICTURES, BY END USER, 2018–2025 (USD MILLION) 135
TABLE 80 NORTH AMERICA: GASTROINTESTINAL MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY PRODUCT, 2018–2025 (USD MILLION) 136
TABLE 81 NORTH AMERICA: HANDHELD INSTRUMENTS FOR GASTROINTESTINAL MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY TYPE,
2018–2025 (USD MILLION) 136
TABLE 82 NORTH AMERICA: INFLATION DEVICES FOR GASTROINTESTINAL MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY TYPE,
2018–2025 (USD MILLION) 136
TABLE 83 NORTH AMERICA: GASTROINTESTINAL MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY END USER, 2018–2025 (USD MILLION) 136
9.2.1 US 137
9.2.1.1 The US dominated the North American minimally invasive surgical instruments market in 2020 137
TABLE 84 US: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 138
TABLE 85 US: HANDHELD INSTRUMENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 139
TABLE 86 US: INFLATION DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 139
TABLE 87 US: CUTTING INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION) 139
TABLE 88 US: GUIDING DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 140
TABLE 89 US: ELECTROSURGICAL & ELECTROCAUTERY INSTRUMENTS MARKET,
BY TYPE, 2019–2026 (USD MILLION) 140
TABLE 90 US: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET,
BY TYPE OF SURGERY, 2019–2026 (USD MILLION) 140
TABLE 91 US: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY END USER, 2019–2026 (USD MILLION) 141
9.2.2 CANADA 141
9.2.2.1 Increasing prevalence of cancer and the rising incidence of IBD drive the market growth in Canada 141
TABLE 92 CANADA: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET,
BY PRODUCT, 2019–2026 (USD MILLION) 142
TABLE 93 CANADA: HANDHELD INSTRUMENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 142
TABLE 94 CANADA: INFLATION DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 143
TABLE 95 CANADA: CUTTING INSTRUMENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 143
TABLE 96 CANADA: GUIDING DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 143
TABLE 97 CANADA: ELECTROSURGICAL & ELECTROCAUTERY INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION) 144
TABLE 98 CANADA: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY TYPE OF SURGERY, 2019–2026 (USD MILLION) 144
TABLE 99 CANADA: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET,
BY END USER, 2019–2026 (USD MILLION) 144
9.3 EUROPE 145
TABLE 100 EUROPE: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET,
BY COUNTRY, 2019–2026 (USD MILLION) 145
TABLE 101 EUROPE: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET,
BY PRODUCT, 2019–2026 (USD MILLION) 146
TABLE 102 EUROPE: HANDHELD INSTRUMENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 146
TABLE 103 EUROPE: INFLATION DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 147
TABLE 104 EUROPE: CUTTING INSTRUMENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 147
TABLE 105 EUROPE: GUIDING DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 147
TABLE 106 EUROPE: ELECTROSURGICAL & ELECTROCAUTERY INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION) 148
TABLE 107 EUROPE: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY TYPE OF SURGERY, 2019–2026 (USD MILLION) 148
TABLE 108 EUROPE: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET,
BY END USER, 2019–2026 (USD MILLION) 148
9.3.1 GERMANY 149
9.3.1.1 A well-established healthcare system in Germany is expected to boost the use of medical devices, inclusive of MIS instruments 149
TABLE 109 GERMANY: KEY MACROINDICATORS 149
TABLE 110 GERMANY: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET,
BY PRODUCT, 2019–2026 (USD MILLION) 150
TABLE 111 GERMANY: HANDHELD INSTRUMENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 150
TABLE 112 GERMANY: INFLATION DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 151
TABLE 113 GERMANY: CUTTING INSTRUMENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 151
TABLE 114 GERMANY: GUIDING DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 151
TABLE 115 GERMANY: ELECTROSURGICAL & ELECTROCAUTERY INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION) 152
TABLE 116 GERMANY: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY TYPE OF SURGERY, 2019–2026 (USD MILLION) 152
TABLE 117 GERMANY: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET,
BY END USER, 2019–2026 (USD MILLION) 152
9.3.2 UK 153
9.3.2.1 High incidence of cancer in the UK to boost the adoption of MIS instruments 153
TABLE 118 UK: KEY MACROINDICATORS 154
TABLE 119 UK: MINIMALLY INVASIVE INSTRUMENTS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 154
TABLE 120 UK: HANDHELD INSTRUMENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 155
TABLE 121 UK: INFLATION DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 155
TABLE 122 UK: CUTTING INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION) 155
TABLE 123 UK: GUIDING DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 156
TABLE 124 UK: ELECTROSURGICAL & ELECTROCAUTERY INSTRUMENTS MARKET,
BY TYPE, 2019–2026 (USD MILLION) 156
TABLE 125 UK: MINIMALLY INVASIVE INSTRUMENTS MARKET, BY TYPE OF SURGERY, 2019–2026 (USD MILLION) 156
TABLE 126 UK: MINIMALLY INVASIVE INSTRUMENTS MARKET, BY END USER,
2019–2026 (USD MILLION) 157
9.3.3 FRANCE 157
9.3.3.1 An increasing number of hip & knee surgeries in France is expected to drive the market growth for MIS instruments 157
TABLE 127 FRANCE: KEY MACROINDICATORS 158
TABLE 128 FRANCE: MINIMALLY INVASIVE INSTRUMENTS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 158
TABLE 129 FRANCE: HANDHELD INSTRUMENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 158
TABLE 130 FRANCE: INFLATION DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 159
TABLE 131 FRANCE: CUTTING INSTRUMENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 159
TABLE 132 FRANCE: GUIDING DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 159
TABLE 133 FRANCE: ELECTROSURGICAL & ELECTROCAUTERY INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION) 160
TABLE 134 FRANCE: MINIMALLY INVASIVE INSTRUMENTS MARKET, BY TYPE OF SURGERY, 2019–2026 (USD MILLION) 160
TABLE 135 FRANCE: MINIMALLY INVASIVE INSTRUMENTS MARKET, BY END USER, 2019–2026 (USD MILLION) 160
9.3.4 ITALY 161
9.3.4.1 Increasing incidence of chronic conditions to drive the market growth in Italy 161
TABLE 136 ITALY: MINIMALLY INVASIVE INSTRUMENTS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 162
TABLE 137 ITALY: HANDHELD INSTRUMENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 162
TABLE 138 ITALY: INFLATION DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 163
TABLE 139 ITALY: CUTTING INSTRUMENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 163
TABLE 140 ITALY: GUIDING DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 163
TABLE 141 ITALY: ELECTROSURGICAL & ELECTROCAUTERY INSTRUMENTS MARKET,
BY TYPE, 2019–2026 (USD MILLION) 164
TABLE 142 ITALY: MINIMALLY INVASIVE INSTRUMENTS MARKET, BY TYPE OF SURGERY, 2019–2026 (USD MILLION) 164
TABLE 143 ITALY: MINIMALLY INVASIVE INSTRUMENTS MARKET, BY END USER,
2019–2026 (USD MILLION) 164
9.3.5 SPAIN 165
9.3.5.1 Increasing incidence of CVD to boost the adoption of MIS and drive the overall market growth in Spain 165
TABLE 144 SPAIN: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET,
BY PRODUCT, 2019–2026 (USD MILLION) 165
TABLE 145 SPAIN: HANDHELD INSTRUMENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 166
TABLE 146 SPAIN: INFLATION DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 166
TABLE 147 SPAIN: CUTTING INSTRUMENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 166
TABLE 148 SPAIN: GUIDING DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 167
TABLE 149 SPAIN: ELECTROSURGICAL & ELECTROCAUTERY INSTRUMENTS MARKET,
BY TYPE, 2019–2026 (USD MILLION) 167
TABLE 150 SPAIN: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET,
BY TYPE OF SURGERY, 2019–2026 (USD MILLION) 167
TABLE 151 SPAIN: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET,
BY END USER, 2019–2026 (USD MILLION) 168
9.3.6 REST OF EUROPE 168
TABLE 152 ROE: HEALTHCARE EXPENDITURE, BY COUNTRY, 2010 VS. 2018 (% OF GDP) 169
TABLE 153 ROE: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 169
TABLE 154 ROE: HANDHELD INSTRUMENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 170
TABLE 155 ROE: INFLATION DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 170
TABLE 156 ROE: CUTTING INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION) 170
TABLE 157 ROE: GUIDING DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 171
TABLE 158 ROE: ELECTROSURGICAL & ELECTROCAUTERY INSTRUMENTS MARKET,
BY TYPE, 2019–2026 (USD MILLION) 171
TABLE 159 ROE: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET,
BY TYPE OF SURGERY, 2019–2026 (USD MILLION) 171
TABLE 160 ROE: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY END USER, 2019–2026 (USD MILLION) 172
9.4 ASIA PACIFIC 172
FIGURE 28 ASIA PACIFIC: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SNAPSHOT 173
TABLE 161 ASIA PACIFIC: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET,
BY COUNTRY, 2019–2026 (USD MILLION) 174
TABLE 162 ASIA PACIFIC: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET,
BY PRODUCT, 2019–2026 (USD MILLION) 174
TABLE 163 ASIA PACIFIC: HANDHELD INSTRUMENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 175
TABLE 164 ASIA PACIFIC: INFLATION DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 175
TABLE 165 ASIA PACIFIC: CUTTING INSTRUMENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 175
TABLE 166 ASIA PACIFIC: GUIDING DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 176
TABLE 167 ASIA PACIFIC: ELECTROSURGICAL & ELECTROCAUTERY INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION) 176
TABLE 168 ASIA PACIFIC: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET,
BY TYPE OF SURGERY, 2019–2026 (USD MILLION) 176
TABLE 169 ASIA PACIFIC: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET,
BY END USER, 2019–2026 (USD MILLION) 177
9.4.1 CHINA 177
9.4.1.1 China dominated the APAC market for MIS instruments in 2020 177
TABLE 170 CHINA: KEY MACROINDICATORS 178
TABLE 171 CHINA: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET,
BY PRODUCT, 2019–2026 (USD MILLION) 178
TABLE 172 CHINA: HANDHELD INSTRUMENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 178
TABLE 173 CHINA: INFLATION DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 179
TABLE 174 CHINA: CUTTING INSTRUMENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 179
TABLE 175 CHINA: GUIDING DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 179
TABLE 176 CHINA: ELECTROSURGICAL & ELECTROCAUTERY INSTRUMENTS MARKET,
BY TYPE, 2019–2026 (USD MILLION) 180
TABLE 177 CHINA: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET,
BY TYPE OF SURGERY, 2019–2026 (USD MILLION) 180
TABLE 178 CHINA: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET,
BY END USER, 2019–2026 (USD MILLION) 180
9.4.2 JAPAN 181
9.4.2.1 Rising geriatric population in Japan to increase the prevalence of chronic conditions, supporting market growth in Japan 181
TABLE 179 JAPAN: KEY MACROINDICATORS 182
TABLE 180 JAPAN: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET,
BY PRODUCT, 2019–2026 (USD MILLION) 182
TABLE 181 JAPAN: HANDHELD INSTRUMENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 183
TABLE 182 JAPAN: INFLATION DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 183
TABLE 183 JAPAN: CUTTING INSTRUMENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 183
TABLE 184 JAPAN: GUIDING DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 184
TABLE 185 JAPAN: ELECTROSURGICAL & ELECTROCAUTERY INSTRUMENTS MARKET,
BY TYPE, 2019–2026 (USD MILLION) 184
TABLE 186 JAPAN: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET,
BY TYPE OF SURGERY, 2019–2026 (USD MILLION) 184
TABLE 187 JAPAN: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET,
BY END USER, 2019–2026 (USD MILLION) 185
 
9.4.3 INDIA 185
9.4.3.1 Healthcare infrastructure improvements and increasing geriatric population to drive the market growth in India 185
TABLE 188 INDIA: KEY MACROINDICATORS 186
TABLE 189 INDIA: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET,
BY PRODUCT, 2019–2026 (USD MILLION) 186
TABLE 190 INDIA: HANDHELD INSTRUMENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 187
TABLE 191 INDIA: INFLATION DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 187
TABLE 192 INDIA: CUTTING INSTRUMENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 187
TABLE 193 INDIA: GUIDING DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 188
TABLE 194 INDIA: ELECTROSURGICAL & ELECTROCAUTERY INSTRUMENTS MARKET,
BY TYPE, 2019–2026 (USD MILLION) 188
TABLE 195 INDIA: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET,
BY TYPE OF SURGERY, 2019–2026 (USD MILLION) 188
TABLE 196 INDIA: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET,
BY END USER, 2019–2026 (USD MILLION) 189
9.4.4 REST OF ASIA PACIFIC 189
TABLE 197 ROAPAC: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET,
BY PRODUCT, 2019–2026 (USD MILLION) 190
TABLE 198 ROAPAC: HANDHELD INSTRUMENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 190
TABLE 199 ROAPAC: INFLATION DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 191
TABLE 200 ROAPAC: CUTTING INSTRUMENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 191
TABLE 201 ROAPAC: GUIDING DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 191
TABLE 202 ROAPAC: ELECTROSURGICAL & ELECTROCAUTERY INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION) 192
TABLE 203 ROAPAC: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET,
BY TYPE OF SURGERY, 2019–2026 (USD MILLION) 192
TABLE 204 ROAPAC: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET,
BY END USER, 2019–2026 (USD MILLION) 192
9.5 LATIN AMERICA 193
9.5.1 INCREASING HEALTHCARE EXPENDITURE AND EFFORTS TO IMPLEMENT UNIVERSAL HEALTH COVERAGE IN THE REGION TO SUPPORT MARKET GROWTH 193
TABLE 205 LATIN AMERICA: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET,
BY PRODUCT, 2019–2026 (USD MILLION) 194
TABLE 206 LATIN AMERICA: HANDHELD INSTRUMENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 194
TABLE 207 LATIN AMERICA: INFLATION DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 195
TABLE 208 LATIN AMERICA: CUTTING INSTRUMENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 195
TABLE 209 LATIN AMERICA: GUIDING DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 195
TABLE 210 LATIN AMERICA: ELECTROSURGICAL & ELECTROCAUTERY INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION) 196
TABLE 211 LATIN AMERICA: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET,
BY TYPE OF SURGERY, 2019–2026 (USD MILLION) 196
TABLE 212 LATIN AMERICA: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET,
BY END USER, 2019–2026 (USD MILLION) 196
9.6 MIDDLE EAST & AFRICA 197
9.6.1 STRENGTHENING OF HEALTHCARE INFRASTRUCTURE IN THE REGION TO SUPPORT THE MARKET GROWTH FOR MIS 197
TABLE 213 MIDDLE EAST & AFRICA: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 198
TABLE 214 MIDDLE EAST & AFRICA: HANDHELD INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION) 198
TABLE 215 MIDDLE EAST & AFRICA: INFLATION DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 199
TABLE 216 MIDDLE EAST & AFRICA: CUTTING INSTRUMENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 199
TABLE 217 MIDDLE EAST & AFRICA: GUIDING DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 199
TABLE 218 MIDDLE EAST & AFRICA: ELECTROSURGICAL & ELECTROCAUTERY INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION) 200
TABLE 219 MIDDLE EAST & AFRICA: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY TYPE OF SURGERY, 2019–2026 (USD MILLION) 200
TABLE 220 MIDDLE EAST & AFRICA: MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY END USER, 2019–2026 (USD MILLION) 201

Lateral Flow Assay Components Market by Type, Application Type (Clinical Testing (Infectious, Cardiac Marker Test) Veterinary, Food Safety), Technique...

Publisher:        MarketsandMarkets

# of Pages:        224

Rating: 

1 User License $4,950

Publication Date:  April, 2022

Price:       $4,950 / User License




1 INTRODUCTION 33
1.1 OBJECTIVES OF THE STUDY 33
1.2 MARKET DEFINITION 33
1.2.1 CATEGORY-WISE INCLUSIONS AND EXCLUSIONS
IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 33
1.3 MARKET SCOPE 34
1.3.1 MARKETS COVERED 34
FIGURE 1 LATERAL FLOW ASSAY COMPONENTS MARKET SEGMENTATION 34
1.3.2 YEARS CONSIDERED FOR THE STUDY 35
1.4 CURRENCY 35
TABLE 1 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD 35
1.5 STAKEHOLDERS 35
2 RESEARCH METHODOLOGY 36
2.1 RESEARCH APPROACH 36
FIGURE 2 RESEARCH DESIGN 36
2.1.1 SECONDARY DATA 36
2.1.1.1 Key data from secondary sources 37
2.1.2 PRIMARY DATA 38
2.1.2.1 Primary sources 38
2.1.2.2 Key data from primary sources 39
2.1.2.3 Breakdown of primaries 39
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE):
BY COMPANY TYPE, DESIGNATION, AND REGION 39
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY END USER, DESIGNATION, AND REGION 40
2.2 MARKET SIZE ESTIMATION 40
FIGURE 5 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS (2021) 41
FIGURE 6 SUPPLY-SIDE ANALYSIS: LATERAL FLOW ASSAY COMPONENTS MARKET (2021) 42
2.3 MARKET BREAKDOWN & DATA TRIANGULATION 44
FIGURE 7 DATA TRIANGULATION METHODOLOGY 45
2.4 KEY INDUSTRY INSIGHTS 46
2.5 LIMITATIONS 46
2.5.1 METHODOLOGY-RELATED LIMITATIONS 46
2.6 RISK ASSESSMENT 47
2.7 ASSUMPTIONS FOR THE STUDY 47
 
3 EXECUTIVE SUMMARY 48
FIGURE 8 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2022 VS. 2027 (USD MILLION) 48
FIGURE 9 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2022 VS. 2027 (USD MILLION) 49
FIGURE 10 LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION,
2022 VS. 2027 (USD MILLION) 50
FIGURE 11 LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2022 VS. 2027 (USD MILLION) 51
FIGURE 12 GEOGRAPHICAL SNAPSHOT OF THE LATERAL FLOW ASSAY COMPONENTS MARKET 52
4 PREMIUM INSIGHTS 53
4.1 LATERAL FLOW ASSAY COMPONENTS MARKET OVERVIEW 53
FIGURE 13 RISING NUMBER OF LOCAL MANUFACTURERS FOR COMPONENTS IS DRIVING THE GROWTH OF THE LATERAL FLOW ASSAY COMPONENTS MARKET 53
4.2 REGIONAL MIX: LATERAL FLOW ASSAY COMPONENTS MARKET 54
FIGURE 14 APAC TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD 54
4.3 ASIA PACIFIC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE AND COUNTRY 55
FIGURE 15 MEMBRANES ACCOUNTED FOR THE LARGEST SHARE OF THE ASIA PACIFIC MARKET IN 2021 55
4.4 LATERAL FLOW ASSAY COMPONENTS MARKET: GEOGRAPHICAL GROWTH OPPORTUNITIES 56
4.5 LATERAL FLOW ASSAY COMPONENTS MARKET: DEVELOPED VS. DEVELOPING COUNTRIES 56
5 MARKET OVERVIEW 57
5.1 INTRODUCTION 57
5.2 MARKET DYNAMICS: IMPACT ANALYSIS 57
5.2.1 DRIVERS 58
5.2.1.1 Growing demand for lateral flow assay kits due
to the COVID-19 pandemic 58
5.2.1.2 Growing usage of home-based lateral flow assay devices 58
5.2.1.3 Growing demand for point-of-care testing 58
5.2.1.4 Increasing public-private investments to develop lateral flow assays 59
5.2.2 RESTRAINTS 59
5.2.2.1 Availability of alternative diagnostic technologies 59
5.2.3 OPPORTUNITIES 59
5.2.3.1 Evolving applications of lateral flow assays 59
5.2.4 CHALLENGES 60
5.2.4.1 Requirement of specialized storage and shipping facilities for membranes 60
5.3 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 60
5.4 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES (YC-YCC) IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 60
FIGURE 16 YC–YCC SHIFT IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 61
5.5 AVERAGE SELLING PRICE TREND 61
TABLE 2 AVERAGE SELLING PRICE OF LATERAL FLOW ASSAY COMPONENTS,
BY REGION, 2021 (USD) 61
5.6 ECOSYSTEM MARKET MAP 62
FIGURE 17 ECOSYSTEM: LATERAL FLOW ASSAY COMPONENTS MARKET (2021) 62
5.7 PATENT ANALYSIS 63
5.7.1 PATENT PUBLICATION TRENDS FOR LATERAL FLOW ASSAYS 63
FIGURE 18 GLOBAL PATENT PUBLICATION TRENDS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET, 2016–2021 64
5.7.2 JURISDICTION ANALYSIS: TOP APPLICANTS (COUNTRIES) FOR PATENTS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 64
FIGURE 19 JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES FOR LATERAL FLOW ASSAYS COMPONENTS, 2016–2021 64
5.8 VALUE CHAIN ANALYSIS 65
5.9 REGULATORY LANDSCAPE 66
TABLE 3 REGULATORY STANDARDS/APPROVALS REQUIRED FOR LATERAL FLOW IMMUNOASSAY PRODUCTS, BY COUNTRY/REGION 66
5.9.1 NORTH AMERICA 66
5.9.2 EUROPE 67
5.9.3 ASIA PACIFIC 67
5.9.3.1 India 67
5.9.3.2 China 67
5.9.3.3 Japan 68
5.10 TECHNOLOGY ANALYSIS 69
5.10.1 KEY TECHNOLOGY: LATERAL FLOW ASSAYS 69
5.11 KEY CONFERENCES & EVENTS DURING 2021–2023 69
TABLE 4 LATERAL FLOW ASSAY COMPONENTS MARKET: DETAILED LIST OF CONFERENCES & EVENTS 69
5.12 KEY STAKEHOLDERS & BUYING CRITERIA 70
5.12.1 KEY STAKEHOLDERS IN THE BUYING PROCESS 70
FIGURE 20 INFLUENCE OF STAKEHOLDERS IN THE BUYING PROCESS FOR THE TOP 3 APPLICATIONS 70
TABLE 5 INFLUENCE OF STAKEHOLDERS IN THE BUYING PROCESS FOR THE TOP 3 APPLICATIONS 70
5.12.2 BUYING CRITERIA 71
FIGURE 21 KEY BUYING CRITERIA FOR THE TOP 3 APPLICATIONS 71
TABLE 6 KEY BUYING CRITERIA FOR THE TOP 3 APPLICATIONS 71
5.13 PORTER’S FIVE FORCES ANALYSIS 72
TABLE 7 LATERAL FLOW ASSAY COMPONENTS MARKET:
PORTER’S FIVE FORCES ANALYSIS 72
5.13.1 THREAT FROM NEW ENTRANTS 72
5.13.2 THREAT FROM SUBSTITUTES 72
5.13.3 BARGAINING POWER OF BUYERS 73
5.13.4 BARGAINING POWER OF SUPPLIERS 73
5.13.5 INTENSITY OF COMPETITIVE RIVALRY 73
6 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE 74
6.1 INTRODUCTION 75
TABLE 8 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 75
6.2 MEMBRANES 75
TABLE 9 LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE,
2020–2027 (USD MILLION) 76
TABLE 10 LATERAL FLOW ASSAY COMPONENTS MARKET FOR MEMBRANES,
BY COUNTRY, 2020–2027 (USD MILLION) 76
6.2.1 NITROCELLULOSE MEMBRANES 77
6.2.1.1 Advantages of nitrocellulose membranes such as high protein-binding affinity and compatibility with a wide range of detection methods to drive market growth 77
TABLE 11 LATERAL FLOW ASSAY COMPONENTS MARKET FOR NITROCELLULOSE MEMBRANES, BY COUNTRY, 2020–2027 (USD MILLION) 77
TABLE 12 LATERAL FLOW ASSAY COMPONENTS MARKET FOR NITROCELLULOSE MEMBRANES (1 X 1 M SHEETS), BY REGION, 2020–2027 (IN THOUSANDS) 78
TABLE 13 LATERAL FLOW ASSAY COMPONENTS MARKET FOR NITROCELLULOSE MEMBRANES (20 MM X 1 M ROLLS), BY REGION, 2020–2027 (IN MILLIONS) 78
6.2.2 OTHER MEMBRANES 78
TABLE 14 LATERAL FLOW ASSAY COMPONENTS MARKET FOR OTHER MEMBRANES,
BY COUNTRY, 2020–2027 (USD MILLION) 79
6.3 PADS 80
TABLE 15 EXAMPLES OF DIFFERENT MATERIALS USED IN MANUFACTURING LATERAL FLOW ASSAY PADS 80
TABLE 16 LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 80
TABLE 17 LATERAL FLOW ASSAY COMPONENTS MARKET FOR PADS, BY COUNTRY, 2020–2027 (USD MILLION) 81
6.3.1 SAMPLE PADS 81
6.3.1.1 Ability to promote even and controlled distribution of samples to drive market growth 81
TABLE 18 LATERAL FLOW ASSAY COMPONENTS MARKET FOR SAMPLE PADS,
BY COUNTRY, 2020–2027 (USD MILLION) 82
6.3.2 CONJUGATE PADS 82
6.3.2.1 Conjugate pads play an important role in controlling the performance of lateral flow immunoassays 82
TABLE 19 LATERAL FLOW ASSAY COMPONENTS MARKET FOR CONJUGATE PADS,
BY COUNTRY, 2020–2027 (USD MILLION) 83
6.3.3 ABSORBENT PADS 84
6.3.3.1 Absorbent pads prevent backflow—a key factor driving market growth 84
TABLE 20 LATERAL FLOW ASSAY COMPONENTS MARKET FOR ABSORBENT PADS,
BY COUNTRY, 2020–2027 (USD MILLION) 84
6.4 OTHER COMPONENTS 84
TABLE 21 OTHER LATERAL FLOW ASSAY COMPONENTS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 85
7 LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION 86
7.1 INTRODUCTION 87
TABLE 22 LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 87
7.2 CLINICAL TESTING 87
TABLE 23 LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 88
TABLE 24 LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING APPLICATIONS,
BY COUNTRY, 2020–2027 (USD MILLION) 88
7.2.1 INFECTIOUS DISEASE TESTING 89
7.2.1.1 Rising demand for infectious disease testing in emerging markets to drive market growth 89
TABLE 25 LATERAL FLOW ASSAY COMPONENTS MARKET FOR INFECTIOUS DISEASE TESTING, BY COUNTRY, 2020–2027 (USD MILLION) 89
7.2.2 PREGNANCY & FERTILITY TESTING 90
7.2.2.1 Growing infertility levels due to changing lifestyles—a key factor driving market growth 90
TABLE 26 LATERAL FLOW ASSAY COMPONENTS MARKET FOR PREGNANCY & FERTILITY TESTING, BY COUNTRY, 2020–2027 (USD MILLION) 90
7.2.3 CARDIAC MARKER TESTING 91
7.2.3.1 Rising prevalence of cardiovascular diseases and growing government support to drive growth in this market segment 91
TABLE 27 LATERAL FLOW ASSAY COMPONENTS MARKET FOR CARDIAC MARKER TESTING, BY COUNTRY, 2020–2027 (USD MILLION) 92
7.2.4 CHOLESTEROL TESTING/LIPID PROFILING 92
7.2.4.1 Growing prevalence of obesity and CVD—
a key factor driving market growth 92
TABLE 28 LATERAL FLOW ASSAY COMPONENTS MARKET FOR CHOLESTEROL TESTING/LIPID PROFILING, BY COUNTRY, 2020–2027 (USD MILLION) 93
7.2.5 DRUGS-OF-ABUSE TESTING 93
7.2.5.1 Technological advancements and a growing focus on workplace
drug testing are driving market growth 93
TABLE 29 LATERAL FLOW ASSAY COMPONENTS MARKET FOR DRUGS-OF-ABUSE TESTING, BY COUNTRY, 2020–2027 (USD MILLION) 94
7.2.6 OTHER CLINICAL TESTING APPLICATIONS 94
TABLE 30 LATERAL FLOW ASSAY COMPONENTS MARKET FOR OTHER CLINICAL TESTING APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 95
7.3 VETERINARY DIAGNOSTICS 95
7.3.1 INFECTIOUS DISEASE OUTBREAKS (PARTICULARLY IN LARGE LIVESTOCK ANIMALS) TO DRIVE MARKET GROWTH 95
TABLE 31 LATERAL FLOW ASSAY COMPONENTS MARKET FOR VETERINARY DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 96
7.4 FOOD SAFETY & ENVIRONMENTAL TESTING 96
7.4.1 HIGH SENSITIVITY AND EASE OF USE ARE KEY FACTORS DRIVING THE DEMAND FOR LATERAL FLOW ASSAYS FOR FOOD SAFETY TESTING 96
TABLE 32 LATERAL FLOW ASSAY COMPONENTS MARKET FOR FOOD SAFETY & ENVIRONMENTAL TESTING APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 97
7.5 DRUG DEVELOPMENT & QUALITY TESTING 97
7.5.1 INCREASING FOCUS ON PRODUCT SAFETY AND QUALITY ASSURANCE TO DRIVE MARKET GROWTH IN THE COMING YEARS 97
TABLE 33 LATERAL FLOW ASSAY COMPONENTS MARKET FOR DRUG DEVELOPMENT & QUALITY TESTING APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 98
8 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE 99
8.1 INTRODUCTION 100
TABLE 34 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 100
8.2 SANDWICH ASSAYS 100
8.2.1 SANDWICH ASSAYS PROVIDE HIGHER LEVELS OF ASSAY SENSITIVITY AND SPECIFICITY THAN OTHER ASSAY TECHNIQUES—A KEY FACTOR DRIVING GROWTH IN THIS MARKET SEGMENT 100
TABLE 35 LATERAL FLOW ASSAY COMPONENTS MARKET FOR SANDWICH ASSAYS,
BY COUNTRY, 2020–2027 (USD MILLION) 101
8.3 COMPETITIVE ASSAYS 101
8.3.1 REDUCED SELECTIVITY AND SENSITIVITY OF COMPETITIVE ASSAYS IN RELATION TO SANDWICH ASSAYS COULD HAMPER MARKET GROWTH 101
TABLE 36 LATERAL FLOW ASSAY COMPONENTS MARKET FOR COMPETITIVE ASSAYS,
BY COUNTRY, 2020–2027 (USD MILLION) 102
8.4 MULTIPLEX DETECTION ASSAYS 102
8.4.1 INCREASING ADOPTION OF MULTI-ANALYTE ASSAYS AMONG CLINICIANS TO DRIVE MARKET GROWTH 102
TABLE 37 LATERAL FLOW ASSAY COMPONENTS MARKET FOR MULTIPLEX DETECTION ASSAYS, BY COUNTRY, 2020–2027 (USD MILLION) 103
9 LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER 104
9.1 INTRODUCTION 105
TABLE 38 LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 105
9.2 MEDICAL DEVICE MANUFACTURING COMPANIES 105
9.2.1 INCREASING USE OF POC TESTS IS DRIVING THE ADOPTION OF LATERAL FLOW ASSAY COMPONENTS AMONG MEDICAL DEVICE MANUFACTURING COMPANIES 105
TABLE 39 LATERAL FLOW ASSAY COMPONENTS MARKET FOR MEDICAL DEVICE MANUFACTURING COMPANIES, BY COUNTRY, 2020–2027 (USD MILLION) 106
9.3 MEDICAL DEVICE CONTRACT MANUFACTURING COMPANIES 106
9.3.1 GROWING INCLINATION TOWARD FAST AND EARLY DIAGNOSIS, ESPECIALLY IN RELATION TO THE CURRENT COVID-19 SCENARIO, WILL DRIVE MARKET GROWTH 106
TABLE 40 LATERAL FLOW ASSAY COMPONENTS MARKET FOR MEDICAL DEVICE CONTRACT MANUFACTURING COMPANIES, BY COUNTRY,
2020–2027 (USD MILLION) 107
 
10 LATERAL FLOW ASSAY COMPONENTS MARKET, BY REGION 108
10.1 INTRODUCTION 109
FIGURE 22 CHINA TO REGISTER THE HIGHEST GROWTH IN THE LATERAL FLOW ASSAY COMPONENTS MARKET DURING THE FORECAST PERIOD 109
TABLE 41 LATERAL FLOW ASSAY COMPONENTS MARKET, BY REGION,
2020–2027 (USD MILLION) 110
10.2 NORTH AMERICA 110
TABLE 42 NORTH AMERICA: MACROECONOMIC INDICATORS 110
FIGURE 23 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET SNAPSHOT 111
TABLE 43 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY COUNTRY, 2020–2027 (USD MILLION) 112
TABLE 44 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 112
TABLE 45 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 112
TABLE 46 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY PAD TYPE, 2020–2027 (USD MILLION) 113
TABLE 47 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY APPLICATION, 2020–2027 (USD MILLION) 113
TABLE 48 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 114
TABLE 49 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY TECHNIQUE, 2020–2027 (USD MILLION) 114
TABLE 50 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY END USER, 2020–2027 (USD MILLION) 115
10.2.1 US 115
10.2.1.1 Increasing R&D investments and venture capital funding from both large and small firms towards the development of lateral flow assay diagnostics to drive market growth in the US 115
TABLE 51 US: MACROECONOMIC INDICATORS 116
TABLE 52 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 116
TABLE 53 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 116
TABLE 54 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 117
TABLE 55 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 117
TABLE 56 US: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 118
TABLE 57 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 118
TABLE 58 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 119
10.2.2 CANADA 119
10.2.2.1 Lateral flow assay components market in Canada is estimated to grow at a relatively lower rate than the US 119
TABLE 59 CANADA: MACROECONOMIC INDICATORS 119
TABLE 60 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 120
TABLE 61 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 120
TABLE 62 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 120
TABLE 63 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 121
TABLE 64 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 121
TABLE 65 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 122
TABLE 66 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 122
10.3 EUROPE 122
TABLE 67 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 123
TABLE 68 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 123
TABLE 69 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 123
TABLE 70 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 124
TABLE 71 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 124
TABLE 72 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 125
TABLE 73 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 125
TABLE 74 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 126
10.3.1 GERMANY 126
10.3.1.1 Growing demand for POC testing to drive the lateral flow assay components market in Germany 126
TABLE 75 GERMANY: MACROECONOMIC INDICATORS 126
TABLE 76 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 127
TABLE 77 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 127
TABLE 78 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 127
TABLE 79 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 128
TABLE 80 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 128
TABLE 81 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 129
TABLE 82 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 129
10.3.2 FRANCE 129
10.3.2.1 High prevalence of age-related chronic diseases and infectious diseases to drive market growth in France 129
TABLE 83 FRANCE: MACROECONOMIC INDICATORS 130
TABLE 84 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 130
TABLE 85 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 130
TABLE 86 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 131
TABLE 87 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 131
TABLE 88 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 132
TABLE 89 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 132
TABLE 90 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 133
10.3.3 UK 133
10.3.3.1 Severe impact of the second wave of COVID-19 in the first half of 2021 resulted in higher adoption of rapid COVID tests in the UK 133
TABLE 91 UK: MACROECONOMIC INDICATORS 134
TABLE 92 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 134
TABLE 93 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 134
TABLE 94 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 135
TABLE 95 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 135
TABLE 96 UK: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 136
TABLE 97 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 136
TABLE 98 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 137
10.3.4 ITALY 137
10.3.4.1 Growing initiatives towards decentralization of medical services in Italy are contributing to the market growth in the country 137
TABLE 99 ITALY: MACROECONOMIC INDICATORS 137
TABLE 100 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 138
TABLE 101 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 138
TABLE 102 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 138
TABLE 103 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 139
TABLE 104 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 139
TABLE 105 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 140
TABLE 106 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 140
10.3.5 SPAIN 140
10.3.5.1 Increasing focus of international organizations and domestic players on the development of POC products in the country to drive market growth 140
TABLE 107 SPAIN: MACROECONOMIC INDICATORS 141
TABLE 108 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 141
TABLE 109 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 142
TABLE 110 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 142
TABLE 111 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 142
TABLE 112 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 143
TABLE 113 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 143
TABLE 114 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 144
10.3.6 REST OF EUROPE 144
TABLE 115 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 144
TABLE 116 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 145
TABLE 117 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 145
TABLE 118 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 145
TABLE 119 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 146
TABLE 120 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 146
TABLE 121 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 147
10.4 ASIA PACIFIC 147
FIGURE 24 ASIA PACIFIC: LATERAL FLOW ASSAY COMPONENTS MARKET SNAPSHOT 148
TABLE 122 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 149
TABLE 123 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 149
TABLE 124 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 149
TABLE 125 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 150
TABLE 126 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 150
TABLE 127 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 151
TABLE 128 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 151
TABLE 129 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 152
10.4.1 CHINA 152
10.4.1.1 Higher exports of lateral flow assay components during the COVID-19 pandemic to drive market growth in the country 152
TABLE 130 CHINA: MACROECONOMIC INDICATORS 153
TABLE 131 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 153
TABLE 132 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 153
TABLE 133 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 154
TABLE 134 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 154
TABLE 135 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 155
TABLE 136 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 155
TABLE 137 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 156
10.4.2 JAPAN 156
10.4.2.1 Increasing prevalence of age-related illnesses driving the growth of the lateral flow assay components market in Japan 156
TABLE 138 JAPAN: MACROECONOMIC INDICATORS 157
TABLE 139 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 157
TABLE 140 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 157
TABLE 141 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 158
TABLE 142 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 158
TABLE 143 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 159
TABLE 144 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 159
TABLE 145 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 160
10.4.3 INDIA 160
10.4.3.1 Increasing number of local manufacturers, growing healthcare concerns, and rising income levels to propel the growth of this market 160
TABLE 146 INDIA: MACROECONOMIC INDICATORS 160
TABLE 147 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 161
TABLE 148 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 161
TABLE 149 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 161
TABLE 150 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 162
TABLE 151 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 162
TABLE 152 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 163
TABLE 153 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 163
10.4.4 AUSTRALIA 164
10.4.4.1 Increasing prevalence of infectious diseases, especially influenza, to drive the growth of the lateral flow assay components market in Australia 164
TABLE 154 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 164
TABLE 155 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 164
TABLE 156 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 165
TABLE 157 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 165
TABLE 158 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 166
TABLE 159 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 166
TABLE 160 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 167
10.4.5 REST OF ASIA PACIFIC 167
TABLE 161 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 167
TABLE 162 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 168
TABLE 163 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 168
TABLE 164 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 168
TABLE 165 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 169
TABLE 166 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 169
TABLE 167 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 170
 
10.5 LATIN AMERICA 170
10.5.1 HIGH DEMAND FOR HIV POC DEVICES IN THE REGION TO SUPPORT THE GROWTH OF THE MARKET 170
TABLE 168 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 171
TABLE 169 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 171
TABLE 170 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD
TYPE, 2020–2027 (USD MILLION) 171
TABLE 171 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY APPLICATION, 2020–2027 (USD MILLION) 172
TABLE 172 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 172
TABLE 173 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY TECHNIQUE, 2020–2027 (USD MILLION) 173
TABLE 174 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY END USER, 2020–2027 (USD MILLION) 173
10.6 MIDDLE EAST & AFRICA 173
10.6.1 SIGNIFICANT SUPPORT FROM GOVERNMENTS AND GLOBAL FIRMS TOWARDS EXPANDING HEALTHCARE SERVICES DRIVES THE ADOPTION OF LATERAL FLOW ASSAYS 173
TABLE 175 MIDDLE EAST & AFRICA: MACROECONOMIC INDICATORS 174
TABLE 176 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY TYPE, 2020–2027 (USD MILLION) 174
TABLE 177 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 175
TABLE 178 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY PAD TYPE, 2020–2027 (USD MILLION) 175
TABLE 179 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY APPLICATION, 2020–2027 (USD MILLION) 175
TABLE 180 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 176
TABLE 181 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY TECHNIQUE, 2020–2027 (USD MILLION) 176
TABLE 182 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY END USER, 2020–2027 (USD MILLION) 177
11 COMPETITIVE LANDSCAPE 178
11.1 OVERVIEW 178
11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 178
FIGURE 25 OVERVIEW OF STRATEGIES ADOPTED BY MAJOR PLAYERS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 179
11.3 REVENUE SHARE ANALYSIS FOR KEY PLAYERS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 179
FIGURE 26 REVENUE SHARE ANALYSIS FOR THE KEY PLAYERS
IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 180
11.4 MARKET SHARE ANALYSIS 180
FIGURE 27 LATERAL FLOW ASSAY COMPONENTS MARKET SHARE ANALYSIS, BY KEY PLAYER (2021) 181
TABLE 183 LATERAL FLOW ASSAY COMPONENTS MARKET: DEGREE OF COMPETITION 182
11.5 R&D ASSESSMENT OF KEY PLAYERS 183
FIGURE 28 R&D EXPENDITURE: MAJOR PLAYERS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET, 2018 VS. 2020 183
11.6 GEOGRAPHIC REVENUE ASSESSMENT OF KEY PLAYERS 183
FIGURE 29 GEOGRAPHIC REVENUE ASSESSMENT: LATERAL FLOW ASSAY COMPONENTS MARKET (2021) 184
11.7 COMPANY EVALUATION QUADRANT 184
11.7.1 STARS 184
11.7.2 PERVASIVE PLAYERS 184
11.7.3 EMERGING LEADERS 185
11.7.4 PARTICIPANTS 185
FIGURE 30 LATERAL FLOW ASSAY COMPONENTS MARKET: COMPANY EVALUATION MATRIX, 2021 185
11.8 COMPETITIVE BENCHMARKING 186
11.8.1 OVERALL COMPANY FOOTPRINT 186
TABLE 184 OVERALL COMPANY FOOTPRINT (17 COMPANIES) 186
TABLE 185 COMPANY FOOTPRINT: BY TYPE (17 COMPANIES) 187
TABLE 186 COMPANY FOOTPRINT: BY REGION (17 COMPANIES) 188
11.9 COMPETITIVE SCENARIO 188
11.9.1 DEALS 189
TABLE 187 DEALS, JANUARY 2019–FEBRUARY 2022 189
11.9.2 OTHER DEVELOPMENTS 189
TABLE 188 OTHER DEVELOPMENTS, JANUARY 2019–FEBRUARY 2022 189
12 COMPANY PROFILES 190
12.1 KEY PLAYERS 190
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
12.1.1 DANAHER CORPORATION (PALL CORPORATION AND CYTIVA LIFE SCIENCE) 190
TABLE 189 DANAHER CORPORATION: BUSINESS OVERVIEW 190
FIGURE 31 DANAHER CORPORATION: COMPANY SNAPSHOT (2020) 191
12.1.2 SARTORIUS STEDIM BIOTECH 195
TABLE 190 SARTORIUS STEDIM BIOTECH: BUSINESS OVERVIEW 195
12.1.3 MERCK KGAA 199
TABLE 191 MERCK KGAA: BUSINESS OVERVIEW 199
FIGURE 33 MERCK KGAA: COMPANY SNAPSHOT (2020) 200
12.1.4 AHLSTROM-MUNKSJÖ 204
TABLE 192 AHLSTROM-MUNKSJÖ: BUSINESS OVERVIEW 204
FIGURE 34 AHLSTROM-MUNKSJÖ: COMPANY SNAPSHOT (2020) 205
12.1.5 ADVANCED MICRODEVICES PVT. LTD. 208
TABLE 193 ADVANCED MICRODEVICES PVT. LTD.: BUSINESS OVERVIEW 208
12.1.6 DCN DIAGNOSTICS 210
TABLE 194 DCN DIAGNOSTICS: BUSINESS OVERVIEW 210
12.2 OTHER PLAYERS 211
12.2.1 FORTIS LIFE SCIENCES 211
TABLE 195 FORTIS LIFE SCIENCES: BUSINESS OVERVIEW 211
12.2.2 HANGZHOU COBETTER FILTRATION EQUIPMENT CO. LTD 212
TABLE 196 HANGZHOU COBETTER FILTRATION EQUIPMENT CO. LTD.:
BUSINESS OVERVIEW 212
12.2.3 AXIVA SICHEM BIOTECH 214
TABLE 197 AXIVA SICHEM BIOTECH: BUSINESS OVERVIEW 214
12.2.4 NUPORE FILTRATION SYSTEM 216
TABLE 198 NUPORE FILTRATION SYSTEM: BUSINESS OVERVIEW 216
12.2.5 BALLYA BIO 217
TABLE 199 BALLYA BIO: BUSINESS OVERVIEW 217
12.2.6 RUNBIO BIOTECH CO. LTD. 219
TABLE 200 RUNBIO BIOTECH CO. LTD.: BUSINESS OVERVIEW 219
12.2.7 NEENAH GESSNER 220
TABLE 201 NEENAH GESSNER: BUSINESS OVERVIEW 220
12.2.8 MAXIM BIOMEDICAL 221
TABLE 202 MAXIM BIOMEDICAL: BUSINESS OVERVIEW 221
12.2.9 CYTODIAGNOSTICS 222
TABLE 203 CYTODIAGNOSTICS: BUSINESS OVERVIEW 222
12.2.10 SENOVA GMBH 223
TABLE 204 SENOVA GMBH: BUSINESS OVERVIEW 223
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
13 APPENDIX 224
13.1 DISCUSSION GUIDE 224
13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 229
13.3 AVAILABLE CUSTOMIZATIONS 231
13.4 RELATED REPORTS 231
13.5 AUTHOR DETAILS 232

US Healthcare Environmental Services Market by Type (Janitorial/Core-Cleaning, Infection Control & Prevention, Front-of-house cleaning & Brand Experie...

Publisher:        MarketsandMarkets

# of Pages:        126

Rating: 

1 User License $4,950

Publication Date:  March, 2022

Price:       $4,950 / User License




1 INTRODUCTION 15
1.1 OBJECTIVES OF THE STUDY 15
1.2 MARKET DEFINITION & SCOPE 15
1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY 16
1.2.2 MARKET SEGMENTATION 16
FIGURE 1 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET SEGMENTATION 16
1.2.3 YEARS CONSIDERED FOR THE STUDY 17
1.3 CURRENCY 17
TABLE 1 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD 17
1.4 STAKEHOLDERS 18
2 RESEARCH METHODOLOGY 19
2.1 RESEARCH APPROACH 19
FIGURE 2 RESEARCH DESIGN 19
2.1.1 SECONDARY RESEARCH 20
2.1.1.1 Key data from secondary sources 21
2.1.2 PRIMARY RESEARCH 21
FIGURE 3 PRIMARY SOURCES 22
2.1.2.1 Key data from primary sources 23
2.1.2.2 Insights from primary experts 23
2.1.2.3 Breakdown of primary interviews 24
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE (SUPPLY & DEMAND SIDE) AND DESIGNATION 24
2.2 MARKET SIZE ESTIMATION 25
FIGURE 5 MARKET SIZE APPROACH – REVENUE SHARE ANALYSIS 25
FIGURE 6 CAGR PROJECTIONS FROM THE ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 26
FIGURE 7 DEMAND-SIDE APPROACH 28
2.3 DATA TRIANGULATION 29
FIGURE 8 DATA TRIANGULATION METHODOLOGY 29
2.4 MARKET RANKING ANALYSIS 30
2.5 ASSUMPTIONS FOR THE STUDY 30
2.6 LIMITATIONS 31
2.6.1 METHODOLOGY-RELATED LIMITATIONS 31
2.6.2 SCOPE-RELATED LIMITATIONS 31
2.7 RISK ASSESSMENT 31
TABLE 2 RISK ASSESSMENT: US HEALTHCARE ENVIRONMENTAL SERVICES MARKET 31
 
3 EXECUTIVE SUMMARY 32
FIGURE 9 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY TYPE,
2021 VS. 2026 (USD MILLION) 32
FIGURE 10 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET,
BY FACILITY TYPE, 2021 VS. 2026 (USD MILLION) 33
4 PREMIUM INSIGHTS 34
4.1 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET OVERVIEW 34
FIGURE 11 STRINGENT REGULATORY GUIDELINES ON INFECTION CONTROL & PREVENTION METHODS IS A KEY FACTOR DRIVING THE MARKET GROWTH 34
4.2 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY TYPE AND FACILITY TYPE 35
FIGURE 12 JANITORIAL/CORE-CLEANING SERVICES ACCOUNTED FOR THE LARGEST SHARE OF THE US HEALTHCARE ENVIRONMENTAL SERVICES
MARKET IN 2020 35
4.3 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY FACILITY TYPE (2021–2026) 36
FIGURE 13 ACUTE CARE FACILITIES TO DOMINATE THE US HEALTHCARE ENVIRONMENTAL SERVICES MARKET DURING THE FORECAST PERIOD 36
5 MARKET OVERVIEW 37
5.1 INTRODUCTION 37
5.2 MARKET DYNAMICS 37
TABLE 3 MARKET DYNAMICS: HEALTHCARE ENVIRONMENTAL SERVICES MARKET 37
5.2.1 MARKET DRIVERS 38
5.2.1.1 Increasing prevalence of Hospital-acquired infections (HAIs) 38
5.2.1.2 Rising number of hospital admissions and surgeries 39
TABLE 4 US: PERCENTAGE INCREASE IN THE NUMBER OF SURGERIES PERFORMED 39
FIGURE 14 TOTAL ADMISSIONS IN ALL US HOSPITALS 40
FIGURE 15 TOTAL NUMBER OF HOSPITALS IN THE US 40
5.2.1.3 Shortage of in-house expertise and the rising need to reduce healthcare costs 41
5.2.1.4 Increasing outsourcing of cleaning services 41
5.2.2 MARKET RESTRAINTS 41
5.2.2.1 Healthcare facilities with an in-house EVS department 41
5.2.3 MARKET OPPORTUNITIES 42
5.2.3.1 Sustained acquisitions among strategic & financial buyers 42
TABLE 5 COMPANY ACQUISITIONS 42
5.2.4 MARKET CHALLENGES 42
5.2.4.1 Noncompliance with cleaning standards by EVS providers 42
5.3 INDUSTRY TRENDS 43
5.3.1 EMERGENCE OF NEW SURFACE DISINFECTANTS &
GREEN CLEANING PRODUCTS 43
5.3.2 DISINFECTION ROBOTS 44
5.3.3 MONITORING TOOLS FOR CLEANING QUALITY ASSESSMENT 44
5.4 TECHNOLOGY ANALYSIS 45
TABLE 6 TECHNOLOGY INNOVATION IN THE HEALTHCARE ENVIRONMENTAL
SERVICES MARKET 45
5.5 PATENT ANALYSIS 45
5.5.1 PATENT PUBLICATION TRENDS FOR HEALTHCARE ENVIRONMENTAL SERVICES 46
FIGURE 16 PATENT PUBLICATION TRENDS (JANUARY 2011–DECEMBER 2021) 46
5.5.2 JURISDICTION AND TOP APPLICANT ANALYSIS 47
FIGURE 17 TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) FOR HEALTHCARE ENVIRONMENTAL SERVICES PATENTS (JANUARY 2011–JANUARY 2022) 47
FIGURE 18 TOP APPLICANT COUNTRIES/REGIONS FOR HEALTHCARE ENVIRONMENTAL SERVICES PATENTS (JANUARY 2011–JANUARY 2022) 48
TABLE 7 LIST OF PATENTS/PATENT APPLICATIONS IN THE HEALTHCARE ENVIRONMENTAL SERVICES MARKET, 2020–2021 48
5.6 IMPACT OF COVID-19 ON THE HEALTHCARE ENVIRONMENTAL SERVICES MARKET 50
6 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY TYPE 51
6.1 INTRODUCTION 52
TABLE 8 US: HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 52
6.2 JANITORIAL SERVICES/CORE-CLEANING SERVICES 52
6.2.1 MANDATORY REGULAR CLEANING AND DISINFECTION OF HEALTHCARE FACILITIES TO DRIVE THE MARKET GROWTH 52
6.3 INFECTION PREVENTION & CONTROL SERVICES 53
TABLE 9 US: INFECTION PREVENTION & CONTROL SERVICE MARKET, BY TYPE,
2019–2026 (USD MILLION) 53
6.3.1 SPECIALIZED CLEANING SERVICES 53
6.3.1.1 Rising adoption of specialized services to reduce HAIs to drive the market growth 53
6.3.2 INFECTION PREVENTION & CONTROL CONSULTATION SERVICES 53
6.3.2.1 The provision of customized environmental services specific
to a healthcare facility ensures market demand 53
6.4 ENHANCED CLEANING TECHNOLOGY 54
6.4.1 RISING DEMAND FOR ADVANCED CLEANING SOLUTIONS TO DRIVE THE SEGMENT GROWTH 54
TABLE 10 EXAMPLES OF COMPANIES PROVIDING TECHNOLOGY & INNOVATION IN HEALTHCARE EVS 54
6.5 FRONT-OF-HOUSE CLEANING AND BRAND EXPERIENCE 56
6.5.1 RISING AWARENESS TOWARDS A CLEAN AND SAFE ENVIRONMENT DURING PANDEMICS TO SUSTAIN THE MARKET GROWTH 56
6.6 OTHER SERVICES 56
 
7 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY FACILITY TYPE 57
7.1 INTRODUCTION 58
FIGURE 19 STATES WITH THE HIGHEST NUMBER OF COVID-19 ADMISSIONS
(FEBRUARY 2022) 58
TABLE 11 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY FACILITY TYPE, 2019–2026 (USD MILLION) 59
7.2 ACUTE-CARE FACILITIES 59
TABLE 12 US: HEALTHCARE ENVIRONMENTAL SERVICES FOR ACUTE-CARE SETTINGS, BY TYPE 2019–2026 (USD MILLION) 59
7.2.1 ACUTE HOSPITALS 60
7.2.1.1 Increasing hospital admissions due to COVID-19 and the rising prevalence of HAIs propel the market growth 60
FIGURE 20 NUMBER OF HAIS REPORTED BY GENERAL ACUTE CARE HOSPITALS
IN THE US (2020) 60
FIGURE 21 HAIS REPORTED BY GENERAL ACUTE CARE HOSPITALS IN THE US (2020) 61
FIGURE 22 HAIS REPORTED BY CRITICAL ACCESS HOSPITALS (CAHS) IN THE US (2018) 61
7.2.2 MILITARY TREATMENT FACILITY 61
7.2.2.1 The increasing number of military ambulatory health services & funding to drive the market growth 61
FIGURE 23 MILITARY HEALTH SYSTEMS FACILITIES IN THE US (2021) 62
7.2.3 CHILDREN’S HOSPITALS 62
7.2.3.1 Rising cases of COVID-19 and infection-related mortality rates among children drive the market growth 62
7.2.4 AMBULATORY SURGERY CENTERS (ASCS) 63
7.2.4.1 ASCs save time and reduce the risk of HAIS; key factor driving the market growth 63
FIGURE 24 US SURGERY CASES BY SETTING: ASC VS. HOPD (2005-2020) 64
7.2.5 ACADEMIC MEDICAL CENTERS (AMCS) 64
7.2.5.1 Healthcare capacity expansion during COVID-19 drives the adoption of healthcare environmental services in AMCs 64
7.3 POST-ACUTE CARE FACILITIES 64
TABLE 13 US: HEALTHCARE ENVIRONMENTAL SERVICES FOR POST-ACUTE CARE SETTINGS, BY TYPE 2019–2026 (USD MILLION) 65
7.3.1 LONG-TERM ACUTE HOSPITALS (LTACH) 65
7.3.1.1 Increasing risk of infection due to prolonged hospital stays to drive the market growth 65
7.3.2 SKILLED NURSING FACILITIES (SNF) 66
7.3.2.1 Increasing admissions of elderly people in skilled nursing facilities to drive the market growth 66
7.3.3 OTHER POST-ACUTE CARE FACILITIES 66
7.4 NON-ACUTE CARE FACILITIES 67
TABLE 14 US: ENVIRONMENTAL SERVICES MARKET FOR NON-ACUTE CARE SETTINGS, BY TYPE, 2019–2026 (USD MILLION) 67
7.4.1 PHYSICIAN’S OFFICES AND CLINICS 67
7.4.1.1 High patient traffic leads to continuous cleaning & maintenance to drive the market growth 67
7.4.2 OTHER NON-ACUTE CARE FACILITIES 68
FIGURE 25 DISTRIBUTION OF INDUSTRY MEDICAL AND HEALTH R&D INVESTMENTS,
BY SEGMENT (2020) 68
8 COMPETITIVE LANDSCAPE 70
8.1 OVERVIEW 70
8.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 70
8.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN THE HEALTHCARE ENVIRONMENTAL SERVICES MARKET 71
8.3 REVENUE SHARE ANALYSIS OF THE TOP MARKET PLAYERS 72
8.4 MARKET RANKING ANALYSIS 73
FIGURE 27 US HEALTHCARE ENVIRONMENTAL SERVICE MARKET RANKING,
BY KEY PLAYER, 2020 73
8.5 COMPETITIVE BENCHMARKING 75
TABLE 15 FOOTPRINT OF COMPANIES IN THE HEALTHCARE ENVIRONMENTAL
SERVICES MARKET 75
TABLE 16 SERVICE FOOTPRINT OF COMPANIES 76
TABLE 17 END-USER FOOTPRINT OF COMPANIES 77
8.6 COMPETITIVE LEADERSHIP MAPPING 77
8.6.1 STARS 78
8.6.2 EMERGING LEADERS 78
8.6.3 PERVASIVE PLAYERS 78
8.6.4 PARTICIPANTS 78
FIGURE 28 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET:
COMPETITIVE LEADERSHIP MAPPING (2021) 79
8.7 COMPETITIVE SCENARIO 80
8.7.1 SERVICE APPROVALS/ENHANCEMENTS 80
8.7.2 DEALS 81
TABLE 19 DEALS, 2018–2022 81
8.7.3 OTHER DEVELOPMENTS 82
9 COMPANY PROFILES 83
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
9.1 SODEXO GLOBAL 83
TABLE 21 SODEXO GLOBAL: BUSINESS OVERVIEW 83
FIGURE 29 SODEXO GLOBAL: COMPANY SNAPSHOT (2021) 84
9.2 COMPASS GROUP (CROTHALL HEALTHCARE (US)) 87
TABLE 22 COMPASS GROUP: BUSINESS OVERVIEW 87
FIGURE 30 COMPASS GROUP: COMPANY SNAPSHOT (2021) 88
 
9.3 ARAMARK CORPORATION 90
TABLE 23 ARAMARK CORPORATION: BUSINESS OVERVIEW 90
FIGURE 31 ARAMARK CORPORATION: COMPANY SNAPSHOT (2021) 91
9.4 HOSPITAL HOUSEKEEPING SYSTEMS (HHS) (US) 94
TABLE 24 HOSPITAL HOUSEKEEPING SYSTEMS (HHS): BUSINESS OVERVIEW 94
9.5 HEALTHCARE SERVICES GROUP, INC. 97
TABLE 25 HEALTHCARE SERVICES GROUP, INC.: BUSINESS OVERVIEW 97
FIGURE 32 HEALTHCARE SERVICES GROUP: COMPANY SNAPSHOT (2020) 98
9.6 ABM INDUSTRIES INCORPORATED 100
TABLE 26 ABM INDUSTRIES INCORPORATED: BUSINESS OVERVIEW 100
FIGURE 33 ABM INDUSTRIES INCORPORATED: COMPANY SNAPSHOT (2020) 101
9.7 OCTOCLEAN 103
TABLE 27 OCTOCLEAN: BUSINESS OVERVIEW 103
9.8 SERVICEMASTER CLEAN (SERVICEMASTER TBS) 105
TABLE 28 SERVICEMASTER CLEAN.: BUSINESS OVERVIEW 105
9.9 CORVUS JANITORIAL SYSTEMS 107
TABLE 29 CORVUS JANITORIAL SYSTEMS: BUSINESS OVERVIEW 107
9.10 BRAVO! BUILDING SERVICES 109
TABLE 30 BRAVO! BUILDING SERVICES: BUSINESS OVERVIEW 109
9.11 POWERLINK ENVIRONMENTAL SERVICES, LLC 111
TABLE 31 POWERLINK ENVIRONMENTAL SERVICES, LLC: BUSINESS OVERVIEW 111
9.12 JANI-KING INTERNATIONAL, INC. 112
TABLE 32 JANI- KING INTERNATIONAL, INC: BUSINESS OVERVIEW 112
9.13 AVI FOOD SYSTEMS(US) 114
TABLE 33 AVI FOOD SYTEMS, INC.: BUSINESS OVERVIEW 114
9.14 SERVICON 115
TABLE 34 SERVICON: BUSINESS OVERVIEW 115
9.15 XANITOS, INC. 117
TABLE 35 XANITOS, INC.: BUSINESS OVERVIEW 117
9.16 STATHAKIS 119
TABLE 36 STATHAKIS: BUSINESS OVERVIEW 119
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
10 APPENDIX 120
10.1 INSIGHTS FROM INDUSTRY EXPERTS 120
10.2 DISCUSSION GUIDE 121
10.3 KNOWLEDGESTORE: MARKETSANDMARKETS SUBSCRIPTION PORTAL 124
10.4 AVAILABLE CUSTOMIZATIONS 126
10.5 RELATED REPORTS 126
10.6 AUTHOR DETAILS 127